Treatments of refractory eosinophilic lung diseases with biologics

Treatments of refractory eosinophilic lung diseases with biologics

Biologics targeting the molecules associated with type 2 inflammation have significantly improved the outcomes of patients with severe eosinophilic asthma and chronic rhinosinusitis with nasal polyps (CRSwNP). Chronic eosinophilic airway/lung diseases including chronic eosinophilic pneumonia, allerg...

Full description

Bibliographic Details
Main Authors: Koichiro Asano, Yuzo Suzuki, Jun Tanaka, Konomi Kobayashi, Yosuke Kamide
Format: Article
Language:English
Published: Elsevier 2023-01-01
Series:Allergology International
Subjects:
Allergic bronchopulmonary mycosis
Chronic eosinophilic pneumonitis
Eosinophilic bronchiolitis
Eosinophilic granulomatosis with polyangiitis
Oral corticosteroid
Online Access:http://www.sciencedirect.com/science/article/pii/S1323893022001216

Internet

http://www.sciencedirect.com/science/article/pii/S1323893022001216

Similar Items